AbCellera
Public
ABCL
Listed Fri Dec 11
Antibody discovery platform using AI and microfluidics to rapidly identify therapeutic antibodies at scale.
IPO details
Market-data summary
Data last checked Tue Aug 18. Optional market data is not yet available where shown as —.
Authority sources
Authority links are not yet available.